Achieving cost effectiveness in Point-of-Care diagnostic devices with frangible seals

The point-of-care (POC) in-vitro diagnostic (IVD) market is continuing to grow, with speculation that IVD could become the leading niche in the medical device industry by 2020 with more than $65 billion in sales. POC testing is supported by continuous technology improvements and the recognition that rapid test results offer economic benefits and potential patient benefits due to faster turnaround of testing results.